Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001058:Apomorphine / Q000494:pharmacology*; D001590:Benztropine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug; D013239:Stereotyped Behavior / Q000187:drug effects; D014326:Tropanes / Q000494:pharmacology*
D000978:Antiparkinson Agents; D011955:Receptors, Drug; D014326:Tropanes; D001590:Benztropine; D009020:Morphine; D006220:Haloperidol; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine